| Literature DB >> 23514203 |
Felix Köpcke1, Benjamin Trinczek, Raphael W Majeed, Björn Schreiweis, Joachim Wenk, Thomas Leusch, Thomas Ganslandt, Christian Ohmann, Björn Bergh, Rainer Röhrig, Martin Dugas, Hans-Ulrich Prokosch.
Abstract
BACKGROUND: Computerized clinical trial recruitment support is one promising field for the application of routine care data for clinical research. The primary task here is to compare the eligibility criteria defined in trial protocols with patient data contained in the electronic health record (EHR). To avoid the implementation of different patient definitions in multi-site trials, all participating research sites should use similar patient data from the EHR. Knowledge of the EHR data elements which are commonly available from most EHRs is required to be able to define a common set of criteria. The objective of this research is to determine for five tertiary care providers the extent of available data compared with the eligibility criteria of randomly selected clinical trials.Entities:
Mesh:
Year: 2013 PMID: 23514203 PMCID: PMC3606452 DOI: 10.1186/1472-6947-13-37
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Figure 1Terminology used in our study. Detailed legend: Each trial contains 1 to n eligibility criteria to describe the patient population under investigation. Each criterion contains one to n patient characteristics, which must be known in order to evaluate whether the criterion is true for a given patient. Each patient characteristic can be mapped to 0 to n data elements in the EHR, which hold the relevant data regarding the characteristic.
Selection of trials included into our study
| Münster | NCT01177033 | intermittent claudication | 299 | 18 |
| Münster | NCT00976222 | pigment epithelial detachment | 3330 | 25 |
| Münster | NCT00961142 | acute leukemia | 2065 | 39 |
| Erlangen | NCT00866684 | skin cancer | 10589 | 21 |
| Erlangen | NCT00025402 | chronic myelogenous leukemia | 1806 | 16 |
| Erlangen | NCT00310583 | mechanical hyperalgesia | 4438 | 31 |
| Heidelberg | NCT01165671 | primary glioblastoma | 22280 | 22 |
| Heidelberg | NCT00176150 | anorexia nervosa | 22280 | 3 |
| Heidelberg | NCT00750971 | lupus erythematosus | 22280 | 21 |
| Düsseldorf | NCT00798525 | critical illnesses | 708 | 13 |
| Düsseldorf | NCT00933374 | urothelial carcinoma | 2091 | 40 |
| Düsseldorf | NCT00977132 | myelodysplastic syndrome | 2351 | 30 |
| Gießen | DOI 10.1111/j.1365-2044.2012.07303.x | general anaesthesia | 5500 | 7 |
| Gießen | NCT01146821 | sepsis | 208 | 49 |
| Gießen | DRKS00003264 | abdominal surgery | 5500 | 16 |
Detailed legend: Each participating hospital selected 3 clinical trials, for which the study identifier, the disease under investigation, as well as the size of the parent population and the number of eligibility criteria are given in this table. Study identifiers beginning with NCT are related to clinicaltrials.gov and the identifier beginning with DRKS relates to the German register germanctr.de. One trial was not registered and thus has no identifier. For this study we show the digital object identifier (DOI) of the publication of the trial’s results. The parent population includes all patients admitted in the fourth quarter of 2011 to the clinical department that conducted the trial.
Eligibility criteria distribution according to semantic categories
| | |||
| Disease, Symptom and Sign | 29.21 | 22.52 | 159 |
| Pregnancy-related activity | 5.17 | 5.24 | 37 |
| Neoplasm status | 3.67 | 3.40 | 24 |
| Disease stage | 2.20 | 2.27 | 16 |
| Allergy | 2.15 | 5.95 | 42 |
| Organ or tissue status | 0.73 | 5.38 | 38 |
| Life expectancy | 0.59 | 0.28 | 2 |
| Pharmaceutical substance or drug | 12.84 | 7.37 | 52 |
| Therapy or surgery | 7.61 | 10.20 | 72 |
| Device | 0.29 | - | 0 |
| Diagnostic or lab results | 14.63 | 19.41 | 137 |
| Receptor status | 0.22 | - | 0 |
| Age | 5.91 | 2.69 | 19 |
| Special patient characteristic | 1.18 | 0.42 | 3 |
| Literacy | 0.65 | 0.28 | 2 |
| Gender | 0.41 | 1.27 | 9 |
| Address | 0.35 | - | 0 |
| Ethnicity | 0.29 | - | 0 |
| Consent | 2.76 | 2.55 | 18 |
| Enrolment in other studies | 2.38 | 1.27 | 9 |
| Capacity | 1.50 | 3.54 | 25 |
| Patient preference | 1.38 | 0.57 | 4 |
| Compliance with protocol | 0.50 | 0.71 | 5 |
| Addictive behaviour | 2.09 | 1.42 | 10 |
| Bedtime | 0.47 | - | 0 |
| Exercise | 0.44 | - | 0 |
| Diet | 0.38 | 0.14 | 1 |
Detailed legend: Distribution of the 706 patient characteristics from 15 clinical trials according to the semantic categories developed by Luo et al. and comparison with the distribution obtained by Luo et al. for 4821 eligibility criteria.
Completeness of patient information in German electronic health records
| Disease, Symptom and Sign | 0.81 | 0.79 | 0.64 | |
| Pregnancy-related activity | 0.16 | 0.38 | 0.06 | |
| Neoplasm status | 0.75 | 0.79 | 0.59 | |
| Disease stage | 0.25 | 0.45 | 0.11 | |
| Allergy | 0.17 | 0.69 | 0.12 | |
| Organ or tissue status | 0.74 | 0.82 | 0.61 | |
| Life expectancy | 0 | - | 0 | |
| Addictive behaviour | 0.90 | 0.82 | 0.74 | |
| Diet | 0 | - | 0 | |
| Pharmaceutical substance or drug | 0.35 | 0.17 | 0.06 | |
| Therapy or surgery | 0.74 | 0.46 | 0.34 | |
| Diagnostic or lab results | 0.54 | 0.36 | 0.20 | |
| Age | 0.95 | 0.94 | 0.89 | |
| Special patient characteristic | 0.33 | 0.76 | 0.25 | |
| Literacy | 0 | - | 0 | |
| Gender | 1.00 | 0.89 | 0.89 | |
| Consent | 0.06 | 0.50 | 0.03 | |
| Enrolment in other studies | 0 | - | 0 | |
| Capacity | 0.16 | 0.76 | 0.12 | |
| Patient preference | 0 | - | 0 | |
| Compliance with protocol | 0 | - | 0 | |
Detailed legend: D = fraction of documentable patient characteristics, i.e. at least one data element containing data on this characteristic was found, F = Average fraction of patients with any data documented in one of these data elements, C = average completeness of patient data for patient characteristics from the semantic category (C=DxF).